ALT positivity of cancer cells is more difficult to be assessed than telomerase positivity since a series of different parameters have to be considered: high and heterogeneous telomeres length, presence of ALT-associated PML bodies (APBs), and presence of DNA circles containing telomeric repeats as refuse of homologous recombination [11]. This evidence concerns the gene GPT and cancer.